It also suppresses inappropriately increased plasma glucagon levels after meals in patients with type 2 diabetes [41] and delays gastric emptying, which plays a critical role in controlling postprandial hyperglycemia in type 2 diabetes, following solid and liquid meals [42]
It can involve insulin resistance, higher androgen levels, acne, facial hair growth, irregular ovulation, weight gain, inflammation, cholesterol changes, blood sugar problems, fatty liver risk, and increased cardiovascular risk
Women who'd stopped the drugs prior to a pregnancy had an average weight gain during their pregnancy that was 7.2 pounds higher than women who hadn't used a GLP-1, the researchers said
While genetics don't predict duration of therapy, they reveal your responsiveness level, helping your clinician optimize your maintenance dose from the start